Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of three experimental hepatitis C therapies compared with Telaprevir in treatment-naive adults; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Experimental Drug 3
• Experimental drug 1
• Experimental drug 2
• Telaprevir (telaprevir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-02-22